Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 115th Congress · S. 456 (Introduced in Senate) — To amend the Federal Food, Drug, and Cosmetic Act to establish a program to increase the development of new drugs to... · Sec. 3

Sec. 3. Improving the timeliness of pediatric studies

305 words·~1 min read·/bill/115/s/456/is/section-3

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 505A(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355a(f) ) is amended by adding at the end the following: The Secretary shall provide to the committee referred to in paragraph
(1)any response issued to an applicant or holder with respect to a proposed pediatric study request. . Section 505A(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355a(d) ) is amended— by redesignating paragraphs
(3)through
(5)as paragraphs
(4)through (6), respectively; and by inserting after paragraph
(2)the following: The Secretary shall review and act upon a submission of a proposed pediatric study request or a sponsor's proposed amendment to a written request for pediatric studies within 120 days of the submission. . The Secretary of Health and Human Services, acting through the internal review committee established under section 505C of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355d ) shall, not later than one year after the date of enactment of this Act, develop and implement a plan to achieve, when appropriate, earlier submission of pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355a ). Such plan shall include recommendations to achieve— earlier discussion of proposed pediatric study requests and written requests with sponsors, and if appropriate, at the meeting required under section 505B(e)(2)(C) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355c(e)(2)(C) ), as amended by section 2; earlier issuance of written requests for a pediatric study under such section 505A, including for investigational new drugs prior to the submission of an application under section 505(b)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355(b)(1) ); and shorter timelines, when appropriate, for the completion of studies pursuant to a written request under such section 505A.
Connectionstraces to 4
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.